Marlins, right-handed Paul Campbell 80 games were suspended for violating Major League Baseball’s Joint Drug Prevention and Treatment Program, announcing Campbell testing positive for Dehydrochlormethyltestosterone (DHCMT)
Originally qualifying for the 21st round for the Rays in the 2017 draft, Campbell was elected to leave Tampa Bay’s organization by Marlins in the draft Rule 5 last December. Making his big league debut this season, Campbell had an 8.74 ERA, 11 1/3 more chances for Miami, with a 21.3% lower strike rate than the average but with a reliable hard contact number. Controls were also an issue, allowing six walks in 11 1/3 of Campbell’s frames.
Through the MLB Players Association, Campbell issued a statement regarding his suspension, stating that he “I have never been deliberately ingested, willing, or intentionally ingested in any form, and I had never heard of DHCMT in this situation.. ”
“Due to the fact that I do not know the origin of the way this substance enters my system, I currently have no possible precautions to support my innocence. Unfortunately, I have become one of the many athletes in many sports offering to the world and asked the members of the anti-doping world to help us figure out why this metabolite is still present in the body. Of an athlete And it eventually cost them a lot of money in their careers.. ”
DHCMT has been a hot topic in recent years as The Wall Street Journal̵7;s Jared Diamond surveyed the piece last August. Kent Emmanuel, Three obstacles, Chris Colabelloand Alex Asher It was a few other MLB players suspended, DHCMT and Emanuel said recently (a tip for The Athletic’s Ken Rosenthal) that the league rejected MLBPA’s offer stating that players could not be suspended. Unless he has more than 100 people, the DHCMT pictograms in his system.